LITTLETON, Colo. and CHICAGO, June 3, 2025 /PRNewswire/ -- DeFloria, Inc., the botanical-drug developer advancing the first of its kind AJA001 oral solution for autism spectrum disorder (ASD), today ...
Fierce’s Rebecca Willumson sat down with Swoop President Scott Rines – live at Digital Pharma East – to discuss some of the most pressing issues in pharma marketing today. Rines kicks off by debunking ...
The integration of cannabinoids into mainstream pharmaceutical practices has been a topic of significant debate and interest over the past decade. As scientific research continues to unravel the ...
HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ — The pharmaceutical industry is undergoing a period of rapid evolution, driven by global health ...
The pharmaceutical industry is engaging in a flurry of biotech deals and shifting clinical trials to China. It does so at a ...
4 analysts have shared their evaluations of Collegium Pharmaceutical (NASDAQ:COLL) during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you'll find ...
For pharmaceutical companies, partnering with reliable API manufacturers is essential to maintain product consistency and regulatory compliance. Manufacturers are expected not only to deliver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results